ImStar Therapeutics

ImStar Therapeutics

ImStar Therapeutics is company developing treatments for ALS, dementia, and other neurodegenerative diseases.

All edits by  Jude Gomila 

Edits on 14 Dec, 2018
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 14 Dec, 2018
Edits made to:
Article (+16/-16 characters)
Article

ImStar Therapeutics is a biotechnology company developing treatments for neurodegenerative diseases. The company is headquartered in Vancouver, British ColumbiaBritish Columbia, Canada and was founded in 2012 by Daniel Wattier and Jean Pierre Julien.

Edits on 9 Dec, 2018
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 9 Dec, 2018
Edits made to:
Article (+29/-29 characters)
Article

ImStar Therapeutics is developing treatments for neurodegenerative diseases such as Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis (ALS), Dementia, Alzheimer's Disease, and Parkinson's Disease. The company is using its unique research findings and understanding of a protein called TAR DNA-binding protein 43 (TDP-43) and its role in inflammatory responses to develop novel treatments for neurodegenerative diseases.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.